Actavis re-introduces oxycodone in USA

Icelandic generic drugs firm Actavis has announced the reintroduction by its Actavis Totowa subsidiary of oxycodone 15mg and 30mg tablet products  to pharmacies and customers in the USA. Oxycodone is the first product  to be manufactured at Actavis' Little Falls, New Jersey, facility  following a recently-completed Food and Drug Administration inspection.

In December 2008, the company reached agreement on a Consent Decree of  Permanent Injunction with the FDA regarding the Actavis Totowa  subsidiary. This Decree only impacted operations at Actavis Totowa's  three New Jersey facilities: two in Totowa and one in Little Falls.

Actavis agreed to not distribute any products from the Actavis Totowa  facilities until it certified completion of certain enumerated  requirements that demonstrate compliance with FDA's current Good  Manufacturing Practice and has passed follow-up agency inspections of  the facilities.